Despite advances in neonatal care, bronchopulmonary dysplasia (BPD), also called chronic lung disease (CLD), remains a major source of morbidity and mortality for extremely low birth weight infants. Over the past five years, we have seen a steady increase in the referrals for infants with chronic lung disease to the Harriet and Ronald Lassin Newborn/Infant Intensive Care Unit (N/IICU) at The Children's Hospital of Philadelphia. As a result, we have gained extensive experience and developed expertise in the comprehensive management of infants with chronic lung disease.
The Newborn and Infant Chronic Lung Disease Program at CHOP is among the first programs devoted solely to treatment of infants with Chronic Lung Disease. Housed within the CHOP Newborn/Infant Intensive Care Unit, our program offers infants with CLD seamless care from evaluation through treatment and long-term followup, employing the newest and most innovative diagnostic therapeutic modalities available.
Our coordinated, multidisciplinary approach to evaluation and management of this life-threatening disease allows clinicians to communicate and work together to provide the most comprehensive, customized care for each child. Our focus: providing life-saving therapy while maximizing long-term quality of life.
The program's multidisciplinary team has extensive experience treating infants with CLD. Our team focuses on providing expert medical care for each patient as well as emotional support for the entire family. Led by attending neonatologists, every member of the team specializes in neonatal/infant care. The team includes:
Our program collaborates with other specialties throughout CHOP to ensure patients receive the comprehensive care they need. Patients benefit from round-the-clock access to every pediatric subspecialty.
Consulting physicians and specialty programs include:
For questions about our program or to make a referral, call and press 9 to transfer: